EpiAxis presents at BioPharm America 2022

EpiAxis presents at BioPharm America 2022

EpiAxis Therapeutics recently presented at BioPharm America 2022, part of Biotech Week Boston, giving investors an update on the company's progress in the epigenetic space. BioPharm America is a conference where the new wave of life science innovators partner to fuel...

read more
EpiAxis enters strategic partnership with UHN

EpiAxis enters strategic partnership with UHN

EpiAxis Therapeutics and University Health Network (UHN) - Canada’s largest and leading research hospital - have entered into a collaboration to study a new approach to prostate cancer treatment. As part of the agreement, EpiAxis Therapeutics will supply its lead...

read more

 

Professor Sudha Rao